J&J vs opioids (Johnson is winning)

Fundamental analysis
In one of the first state opioid cases, an Oklahoma judge ruled against Johnson & Johnson, awarding the state $572 million, well below the over $17 billion the state was seeking in damages.
Meaning... out of the 17 billion, they lost only 3.36%, and they expect to appeal the case, probably lowering this amount.

Technical analysis
On a technical analysis, I still think the risk reward ratio is too small to enter a position now. But technicals are good (not great). So I am keeping this on my watchlist.